Clinical Trial: Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title: Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

Brief Summary: This study will test how well efinaconazole solution (Jublia) works to treat toenail fungal infections in patients who wear polish compared to those who do not.

Detailed Summary: Topical efinaconazole 10% solution is known to be an efficacious and safe treatment modality for toenail onychomycosis. This study will examine the compatibility of topical efinaconazole and nail polish in patients with distal and lateral subungual onychomycosis (DLSO). It is hypothesized that the treatment of DLSO with efinaconazole 10% solution will not be adversely affected by the application of nail polish.
Sponsor: University of Alabama at Birmingham

Current Primary Outcome:

  • Subjective Assessments of Deterioration of Integrity of Nail Polish Quantified on Likert Scale [ Time Frame: 12 weeks ]

    Patients will answer the following question, which will be answered using a Likert scale where 0 represents no alteration in polish and 10 represents complete destruction of the polish:

    • Is the quality of your polish diminished with use of Julia?

  • Subjective Assessments of Deterioration of Integrity of Nail Polish Quantified on Likert Scale [ Time Frame: 52 weeks ]

    Patients will answer the following question, which will be answered using a Likert scale where 0 represents no alteration in polish and 10 represents complete destruction of the polish:

    • Is the quality of your polish diminished with use of Julia?



Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Alabama at Birmingham

Dates:
Date Received: October 16, 2015
Date Started: September 2015
Date Completion: December 2017
Last Updated: April 5, 2017
Last Verified: April 2017